Mumbai: Cipla has announced that the United States Food and Drugs Administration (USFDA) has concluded an inspection at the ...

The FDA conducted an inspection at the manufacturing facility in Virgonagar from Nov. 7 to Nov. 13, according to an exchange ...

Pomerantz LLP is investigating claims on behalf of investors of Humacyte, Inc. ("Humacyte" or the "Company") . Such investors are advised to contact Danielle Peyton at [email protected] or ...

concluded with the issuance of Form 483, a document outlining conditions the regulator believes may need improvement for ...

In today's trade, shares of Grasim, Hero MotoCorp, Cipla, Varun Beverages, Vodafone Idea among others will be in focus due to ...

5 There are no FDA-approved treatments indicated specifically as an aid ... including Achieve's Annual Reports on Form 10-K ...

Several major stocks such as Grasim, Hero MotoCorp, and Honasa Consumer are likely to draw attention due to company updates ...

Following an inspection of its Bengaluru facility, Cipla has received 8 observations in Form 483 from the US Food and Drug Administration (US FDA). The inspection took place at the company’s ...

Cipla: Following an inspection of its Bengaluru facility, the pharma major has received 8 observations in Form 483 from the ...

Chronic bronchitis is a form of chronic obstructive pulmonary disease (COPD ... In the United States, the Food and Drug Administration (FDA) does not regulate supplements the way it regulates ...

Research that was carried out by Baylor College of Medicine and Texas Children's Hospital doctors has led to the U.S. Food ...